Loading organizations...
Key people at Longevity Venture Partners.
Longevity Venture Partners was founded in 2020 by Stephen Rosedale (Founder) and Ronald Wilheim (Founder).
Longevity Venture Partners operates as an early-stage venture capital fund, specializing in the Silvertech, Healthcare, and Wellness sectors. The firm strategically supports its portfolio companies by leveraging a robust commercial ecosystem and an international network. This approach accelerates the development and market entry of innovative solutions.
Founded in 2020, Longevity Venture Partners emerged from the understanding that the expanding longevity economy required dedicated capital and expertise. The firm's establishment was driven by the imperative to back entrepreneurs creating technologies and services that address the evolving needs of an aging global population, aiming to improve independence and well-being.
The fund invests in companies developing products and services for older adults. Longevity Venture Partners’ vision is to foster advancements across its target sectors, empowering people to live healthier, more independent lives. The firm commits to realizing this mission through its investments.
Key people at Longevity Venture Partners.
Longevity Venture Partners was founded in 2020 by Stephen Rosedale (Founder) and Ronald Wilheim (Founder).
Longevity Venture Partners has 5 tracked investments across 5 companies. The latest tracked deal is $3.6M Pre-Seed in Lembas in June 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 11, 2025 | Lembas | $3.6M Pre-Seed | GIL Horsky | Bluestein Ventures, Fresh Fund, Maia Venture, Mandi Ventures, SDH, Siddhi Capital |
| Feb 13, 2025 | Exero Medical | $12.7M Grant / Seed | Longevity Venture Partners | — |
| May 1, 2024 | In-House Health | $4.0M House Health - Seed | TMV, Blake WU | 43, AngelList, B Capital Group, Blume Ventures, KRM Interests LLC, Paul Walker, NEW Enterprise Associates, O'Shaughnessy Ventures, SparkLabs Global Ventures, Utec The University OF Tokyo Edge Capital Partners, Vine Ventures |
| Mar 11, 2022 | Behavidence | $4.3M Seed | Welltech Ventures | ARC Impact |
| Jun 1, 2018 | Decibel Therapeutics | $55.0M Series C | — | Apollo Health Ventures, GV, LearnLaunch Accelerator, Qiming Venture Partners USA, The Column Group, Versant Ventures, Wayne Chang, Bessemer Trust, Foresite Capital, Regeneron Pharmaceuticals, Schroder Adveq, S Cubed Capital, SR ONE, Third Rock Ventures |
